PSY50 - ECONOMIC IMPACT OF ABOVE-LABEL DOSING WITH BIOLOGICS IN PATIENTS WITH MODERATE TO SEVERE PSORIATIC ARTHRITIS
Autor: | Schwartzman, S., Tran, M., Li, Y., Zhou, H., Herrera, V., Palmer, J.B. |
---|---|
Zdroj: | In Value in Health May 2016 19(3):A250-A250 |
Databáze: | ScienceDirect |
Externí odkaz: |